Immune Pharmaceuticals (IMNP) News Today → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free IMNP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineIncyte to acquire immune-focused drug developer Escientmsn.com - April 23 at 8:23 AMVertex Pharmaceuticals Seeks a Second Act With Alpine Immune Deal. What Wall Street Says.msn.com - April 11 at 10:47 PMThese Stocks Are Moving the Most Today: Alpine Immune, Regeneron, Costco, Constellation Brands, CarMax, and Moremsn.com - April 11 at 5:47 PMThese Stocks Are Moving the Most Today: Alpine Immune, Vertex, Regeneron, Costco, Constellation Brands, CarMax, and Moremsn.com - April 11 at 7:33 AMOSE Immunotherapeutics Announces Peer-Reviewed Publication on Novel Myeloid Immune Checkpoint CLEC-1 in Journal of Immunologymarkets.businessinsider.com - April 2 at 3:49 PMAC Immune's Targeted Anti-pTau Active Immunotherapy for Alzheimer's Disease Advances into Phase 2b Trialtmcnet.com - December 15 at 8:51 AMAC Immune Advances Anti-pTau Active Immunotherapy For Alzheimer's Disease Into Phase 2b Trialmarkets.businessinsider.com - December 15 at 8:51 AMImmune Health Supplements Market US$ 63,457.4 Million Valuation in 2033, Experiencing an Impressive CAGR of 10.4% | Future Market Insights Inc.benzinga.com - September 14 at 1:59 PMOrgan Transplant Rejection Medication Market to Surpass USD 7.0 Billion by 2031, Propelled by Remarkable CAGR of 3.9% | Transparency Market Researches-us.finanzas.yahoo.com - June 8 at 10:17 PMTheralase Technologies Inc.: Theralase Announces Appointment of New Independent Directorfinanznachrichten.de - June 6 at 7:46 AMTheralase(R) Announces Appointment of New Independent Directorfinance.yahoo.com - June 6 at 7:46 AMSeveral Down syndrome features may be linked to a hyperactive antiviral immune response – new researchmsn.com - June 5 at 4:43 PMKiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offeringfinanznachrichten.de - June 2 at 10:37 AMKiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offeringfinance.yahoo.com - June 2 at 10:37 AMMedexus Pharmaceuticals Inc.: Medexus to Participate in the LD Micro Invitational XIIIfinanznachrichten.de - June 1 at 8:13 PMBristol Myers (BMY) Loses 10.5% Year-to-Date: What Lies Ahead?finance.yahoo.com - June 1 at 3:12 PMHookipa Pharma (HOOK) Gets a Buy from JMP Securitiesmarkets.businessinsider.com - June 1 at 3:12 PMPhanes Therapeutics announces the appointment of Rita Laeufle, MD, PhD, as Chief Medical Officermarkets.businessinsider.com - May 30 at 11:49 PMX4 Pharmaceuticals (XFOR) Gets a Buy from Stifel Nicolausmarkets.businessinsider.com - May 29 at 10:46 PMHC Wainwright & Co. Reiterates Eledon Pharmaceuticals (ELDN) Buy Recommendationnasdaq.com - May 27 at 1:15 AMCalciMedica Expands Executive Team with New Appointmentsfinance.yahoo.com - May 23 at 9:41 AMBiotech Entrepreneur and Venture Capitalist Dinesh Patel Discusses Therapeutics and Medical Devices with CancerVAX CEO Ryan Daviestechnews.tmcnet.com - May 17 at 12:36 PMMyocardial Infarction Drugs Market Size and Projection from 2023 to 2030marketwatch.com - May 17 at 12:36 PMB.Riley Financial Sticks to Their Buy Rating for X4 Pharmaceuticals (XFOR)markets.businessinsider.com - May 17 at 12:36 PMCAR T-Cell Therapy Market to be Worth $51.6 Billion by 2030 - Exclusive Report by Meticulous Research®benzinga.com - May 16 at 11:33 AMLiver Failure Therapeutics Market 2023-2031: Analyzing Growth Opportunities and Challengesmarketwatch.com - May 12 at 10:26 PMLingering nerve symptoms from Lyme disease may be tied to immune responsereuters.com - May 12 at 7:22 AM8-K: INOVIO PHARMACEUTICALS, INC.marketwatch.com - May 11 at 9:21 PMTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - May 11 at 10:44 AMModerna's Revolutionary Cancer Vaccine Sets Investors Abuzzforbes.com - May 11 at 1:08 AM8-K: Corbus Pharmaceuticals Holdings, Inc.marketwatch.com - May 9 at 11:50 PM10-Q: KIORA PHARMACEUTICALS INCmarketwatch.com - May 9 at 11:50 PMCorbus Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - May 9 at 8:21 AMMizuho Securities Sticks to Their Hold Rating for Corvus Pharmaceuticals (CRVS)markets.businessinsider.com - May 8 at 10:20 PMEQRx lays off more than half its staff, pivots againbizjournals.com - May 8 at 10:20 PMCorvus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Resultsfinance.yahoo.com - May 8 at 5:20 PMXencor Reports First Quarter 2023 Financial Resultsbusinesswire.com - May 8 at 5:20 PMNeedham Maintains Buy Rating for Apellis Pharmaceuticals: Here's What You Need To Knowmarkets.businessinsider.com - May 5 at 1:14 PMH.C. Wainwright Reaffirms Their Buy Rating on X4 Pharmaceuticals (XFOR)markets.businessinsider.com - May 5 at 8:13 AMH.C. Wainwright Sticks to Its Buy Rating for BioCryst (BCRX)markets.businessinsider.com - May 4 at 7:11 AMFDA Approves First-Ever RSV Vaccine for Adults 60 and Oldermsn.com - May 3 at 9:09 PMRigel Reports First Quarter 2023 Financial Results and Provides Business Updatemarkets.businessinsider.com - May 2 at 6:30 PMLatest Developments in the Amyotrophic Lateral Sclerosis Pipeline | Major Companies – Biogen, AbbVie, and Othersmarketwatch.com - May 2 at 1:30 PMDelveInsight Evaluates a Robust Antibody-drug Conjugates in Oncology Clinical Trial Pipeline as 30+ Influential Pharma Players to Set Foot in the 7MMbenzinga.com - May 1 at 3:22 PM2023-2030 Drug Induced Immune Hemolytic Anemia Market Size (Growth and Outlook) includes Company Information | with [102 Pages]marketwatch.com - April 27 at 10:53 PMLatest Trends and Strategies for Immune Thrombocytopenia Drugs Market During 2023-2031marketwatch.com - April 27 at 5:53 PMOSE Immunotherapeutics Reports Full Year 2022 Financial Results and Provides Business Strategy Updatebenzinga.com - April 27 at 12:53 PMTorigen Pharmaceuticals Opens New Headquarters and Promotes Two to Executive Leadershipbenzinga.com - April 25 at 6:25 PMDiabetic Peripheral Neuropathy Treatment Market Report Focuses on Latest Running CAGR Value 2023-2030marketwatch.com - April 23 at 12:18 PMVallon Pharmaceuticals Inc.: Vallon Pharmaceuticals Completes Merger with GRI Bio, Inc.finanznachrichten.de - April 22 at 7:38 AM Get Immune Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNP and its competitors with MarketBeat's FREE daily newsletter. Email Address $25,000 into $109,616 in two months? (Ad)Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time… Go here to watch the most recent trading workshop video at no charge. IMNP Media Mentions By Week IMNP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMNP News Sentiment▼0.000.41▲Average Medical News Sentiment IMNP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMNP Articles This Week▼10▲IMNP Articles Average Week Get Immune Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ASLN News CLVR News TFFP News LIXT News CYCN News PULM News VIRI News KTTA News HEPA News LGVN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMNP) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsThe AI stock to buy right nowStockEarningsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immune Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
